Tefron Ltd.
TFRFF
$6.43
-$0.03-0.46%
OTC PK
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 237.25M | 245.88M | 267.70M | 277.34M | 293.86M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 237.25M | 245.88M | 267.70M | 277.34M | 293.86M |
| Cost of Revenue | 188.64M | 195.10M | 208.74M | 215.94M | 227.38M |
| Gross Profit | 48.62M | 50.77M | 58.95M | 61.40M | 66.48M |
| SG&A Expenses | 32.69M | 33.33M | 34.33M | 34.87M | 35.65M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 397.00K | 639.00K | 639.00K | 639.00K | 639.00K |
| Total Operating Expenses | 228.97M | 236.10M | 250.70M | 258.37M | 270.76M |
| Operating Income | 8.29M | 9.77M | 17.00M | 18.97M | 23.11M |
| Income Before Tax | 5.02M | 6.88M | 14.16M | 15.88M | 19.56M |
| Income Tax Expenses | 2.33M | 1.61M | 2.62M | 3.22M | 4.45M |
| Earnings from Continuing Operations | 2.69 | 5.27 | 11.54 | 12.66 | 15.11 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.69M | 5.27M | 11.54M | 12.66M | 15.11M |
| EBIT | 8.29M | 9.77M | 17.00M | 18.97M | 23.11M |
| EBITDA | 14.93M | 16.45M | 23.98M | 26.30M | 30.44M |
| EPS Basic | 0.22 | 0.42 | 0.92 | 1.00 | 1.20 |
| Normalized Basic EPS | 0.25 | 0.34 | 0.71 | 0.78 | 0.97 |
| EPS Diluted | 0.20 | 0.39 | 0.86 | 0.93 | 1.12 |
| Normalized Diluted EPS | 0.24 | 0.33 | 0.66 | 0.73 | 0.91 |
| Average Basic Shares Outstanding | 49.80M | 50.39M | 50.21M | 50.54M | 50.48M |
| Average Diluted Shares Outstanding | 51.17M | 51.93M | 52.92M | 53.55M | 53.35M |
| Dividend Per Share | -- | 0.16 | 0.16 | 0.16 | 0.16 |
| Payout Ratio | 76.64% | 39.10% | 17.85% | 15.76% | 13.20% |